BioInvent International
Mimoza Demiri Bodén has work experience as a Research Scientist at BioInvent International AB since 2018. Prior to that, they worked as a PhD candidate at Lunds universitet from 2013 to 2017. Mimoza also worked as a Research Project Assistant at The University of Western Australia from February to August 2012.
Mimoza Demiri Bodén completed their education at Lund University. Mimoza obtained a Master's degree in Molecular Biology, which they pursued from 2007 to 2012. Subsequently, from 2013 to 2017, they pursued a Doctor of Philosophy - PhD in Immunology at the same institution.
This person is not in any offices
BioInvent International
BioInvent International AB (Nasdaq Stockholm: BINV) is a clinical-stage biotech company that discovers and develops novel and first-in-class immuno-modulatory antibodies for cancer therapy, with currently three drug candidates in four ongoing clinical programs in Phase l/ll trials for the treatment of hematological cancer and solid tumors, respectively.